CAD 14.56
(3.41%)
Year | Net Income | Net Income Growth |
---|---|---|
2023 | 20.38 Million USD | -23.48% |
2022 | 26.63 Million USD | 243.34% |
2021 | 7.75 Million USD | 70.54% |
2020 | 4.54 Million USD | 40.31% |
2019 | 3.24 Million USD | 497.05% |
2018 | 543 Thousand USD | -87.67% |
2017 | 4.4 Million USD | 111.25% |
2016 | -39.14 Million USD | -2313.06% |
2015 | 1.76 Million USD | 136.66% |
2014 | -4.82 Million USD | -120.58% |
2013 | 23.44 Million USD | 816.94% |
2012 | 2.55 Million USD | 212.98% |
2011 | -2.26 Million USD | -4142.56% |
2010 | 55.99 Thousand USD | 102.16% |
2009 | -2.59 Million USD | 2.31% |
2008 | -2.65 Million USD | 59.22% |
2007 | -6.5 Million USD | 37.11% |
2006 | -10.34 Million USD | -41.29% |
2005 | -7.32 Million USD | 26.25% |
2004 | -9.93 Million USD | 0.0% |
Year | Net Income | Net Income Growth |
---|---|---|
2024 Q1 | 4.92 Million USD | -35.69% |
2024 Q2 | 2.99 Million USD | -39.16% |
2023 Q2 | 3.07 Million USD | 16.95% |
2023 Q4 | 7.65 Million USD | 8.87% |
2023 Q1 | 2.62 Million USD | -86.66% |
2023 FY | 20.38 Million USD | -23.48% |
2023 Q3 | 7.03 Million USD | 128.95% |
2022 Q2 | 2.15 Million USD | 0.14% |
2022 Q4 | 19.68 Million USD | 641.52% |
2022 FY | 26.63 Million USD | 243.34% |
2022 Q1 | 2.14 Million USD | -23.52% |
2022 Q3 | 2.65 Million USD | 23.33% |
2021 Q4 | 2.81 Million USD | 253.02% |
2021 Q1 | 1.33 Million USD | 1425.74% |
2021 Q2 | 2.81 Million USD | 110.31% |
2021 Q3 | 796 Thousand USD | -71.73% |
2021 FY | 7.75 Million USD | 70.54% |
2020 FY | 4.54 Million USD | 40.31% |
2020 Q1 | 2.64 Million USD | -15.08% |
2020 Q2 | 411 Thousand USD | -84.44% |
2020 Q3 | 1.6 Million USD | 290.02% |
2020 Q4 | -101 Thousand USD | -106.3% |
2019 Q2 | 1.39 Million USD | 70.83% |
2019 Q4 | 3.11 Million USD | 249.66% |
2019 Q3 | -2.07 Million USD | -249.07% |
2019 FY | 3.24 Million USD | 497.05% |
2019 Q1 | 816 Thousand USD | 175.21% |
2018 Q2 | 2.12 Million USD | 277.19% |
2018 FY | 543 Thousand USD | -87.67% |
2018 Q4 | -1.08 Million USD | -254.78% |
2018 Q3 | 701 Thousand USD | -67.06% |
2018 Q1 | -1.2 Million USD | -131.45% |
2017 Q3 | 2.7 Million USD | 138.12% |
2017 Q1 | -3.33 Million USD | 70.51% |
2017 FY | 4.4 Million USD | 111.25% |
2017 Q4 | 3.81 Million USD | 41.18% |
2017 Q2 | 1.13 Million USD | 134.1% |
2016 Q3 | -21.78 Million USD | -546.34% |
2016 FY | -39.14 Million USD | -2313.06% |
2016 Q2 | -3.37 Million USD | -25.13% |
2016 Q1 | -2.69 Million USD | -232.06% |
2016 Q4 | -11.29 Million USD | 48.15% |
2015 Q3 | -2.21 Million USD | -297.13% |
2015 FY | 1.76 Million USD | 136.66% |
2015 Q4 | 2.04 Million USD | 192.06% |
2015 Q2 | -558 Thousand USD | -122.29% |
2015 Q1 | 2.5 Million USD | -1.25% |
2014 Q4 | 2.53 Million USD | -68.11% |
2014 FY | -4.82 Million USD | -120.58% |
2014 Q1 | 3.49 Million USD | -77.82% |
2014 Q2 | 4.13 Million USD | 18.11% |
2014 Q3 | 7.94 Million USD | 92.4% |
2013 Q4 | 15.76 Million USD | 383.61% |
2013 Q2 | 2.9 Million USD | 97.2% |
2013 Q1 | 1.47 Million USD | 1.69% |
2013 FY | 23.44 Million USD | 816.94% |
2013 Q3 | 3.26 Million USD | 12.06% |
2012 Q4 | 1.45 Million USD | 89.38% |
2012 FY | 2.55 Million USD | 212.98% |
2012 Q1 | 125.28 Thousand USD | 124.63% |
2012 Q2 | 206.46 Thousand USD | 64.8% |
2012 Q3 | 766.06 Thousand USD | 271.03% |
2011 Q2 | -525.54 Thousand USD | 52.92% |
2011 FY | -2.26 Million USD | -4142.56% |
2011 Q1 | -1.11 Million USD | -1427.47% |
2011 Q4 | -508.62 Thousand USD | -132.51% |
2011 Q3 | -218.75 Thousand USD | 58.38% |
2010 FY | 55.99 Thousand USD | 102.16% |
2010 Q3 | -251.98 Thousand USD | -133.67% |
2010 Q2 | 748.5 Thousand USD | 249.03% |
2010 Q1 | -502.25 Thousand USD | 22.48% |
2010 Q4 | 84.09 Thousand USD | 133.37% |
2009 Q4 | -647.88 Thousand USD | -33.69% |
2009 FY | -2.59 Million USD | 2.31% |
2009 Q1 | -615.34 Thousand USD | -554.05% |
2009 Q2 | -675.3 Thousand USD | -9.74% |
2009 Q3 | -484.61 Thousand USD | 28.24% |
2008 Q4 | -94.08 Thousand USD | -157.57% |
2008 FY | -2.65 Million USD | 59.22% |
2008 Q3 | 163.42 Thousand USD | 109.23% |
2008 Q2 | -1.77 Million USD | -68.83% |
2008 Q1 | -1.04 Million USD | 36.41% |
2007 Q4 | -1.65 Million USD | -56.03% |
2007 Q3 | -1.05 Million USD | 45.82% |
2007 FY | -6.5 Million USD | 37.11% |
2007 Q1 | -1.46 Million USD | -11.24% |
2007 Q2 | -1.95 Million USD | -32.86% |
2006 Q4 | -1.32 Million USD | 27.42% |
2006 Q2 | -4.39 Million USD | -62.22% |
2006 Q3 | -1.81 Million USD | 58.56% |
2006 FY | -10.34 Million USD | -41.29% |
2006 Q1 | -2.7 Million USD | -200.02% |
2005 Q2 | -4.31 Million USD | -190.9% |
2005 Q3 | -3.33 Million USD | 22.79% |
2005 Q4 | 2.7 Million USD | 181.15% |
2005 FY | -7.32 Million USD | 26.25% |
2005 Q1 | 4.75 Million USD | 0.0% |
2004 Q2 | -3.79 Million USD | -438.66% |
2004 Q1 | -703.92 Thousand USD | 0.0% |
2004 Q3 | -1.61 Million USD | 57.4% |
2004 FY | -9.93 Million USD | 0.0% |
Name | Net Income | Net Income Difference |
---|---|---|
Aurora Cannabis Inc. | -69.32 Million CAD | 129.402% |
Avicanna Inc. | -8.74 Million CAD | 333.135% |
Avant Brands Inc. | -5.07 Million CAD | 502.032% |
Cardiol Therapeutics Inc. | -28.12 Million CAD | 172.464% |
Crescita Therapeutics Inc. | -1.98 Million CAD | 1126.334% |
Knight Therapeutics Inc. | -16.83 Million CAD | 221.075% |
MediPharm Labs Corp. | -13.08 Million CAD | 255.798% |
OrganiGram Holdings Inc. | -229.47 Million CAD | 108.882% |
Canopy Growth Corporation | -657.26 Million CAD | 103.101% |
Willow Biosciences Inc. | -13.02 Million CAD | 256.443% |
Auxly Cannabis Group Inc. | -44.51 Million CAD | 145.793% |